Anti-CD25/IL-2R alpha Antibody, Mouse Monoclonal sinobiological 90265-MM07

$243.00
In stock
SKU
90265-MM07
Catalog No.SizePrice (USD)
90265-MM07-100100 µL$251.64

General Information

Product nameAnti-CD25/IL-2R alpha Antibody, Mouse Monoclonal
Validated applicationsELISA (FAQ Protocol)
Species reactivityReacts with: Cynomolgus
SpecificityCynomolgus CD25/IL-2R alpha
ImmunogenRecombinant Cynomolgus CD25/IL-2R alpha Protein (Catalog# 90265-C08H)
PreparationThis antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Cynomolgus CD25/IL-2R alpha (Catalog#90265-C08H; H6WS54; Met1-Arg213). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
SourceMonoclonal Mouse IgG1 Clone #07
PurificationProtein A
Formulation0.2 μm filtered solution in PBS
ConjugateUnconjugated
FormLiquid
ShippingThis antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
StorageThis antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.

Background Information

Full Nameinterleukin 2 receptor, alpha
DescriptionCD25 (alpha-chain of the IL-2 receptor, or IL2RA), is a type I transmembrane glycoprotein with a signal peptide, an extracellular region, a transmembrane region, and a cytoplasmic domain. IL2RA is expressed on activated T cells and regulatory T cells and is capable of binding IL2 with low affinity by itself. However, a ligand-induced high-affinity heterotrimeric receptor complex is produced when IL2RA is associated non-covalently with the IL2 receptor beta and gamma chain, and subsequently initiates the intracellular signal pathways such as MAPK or JAK/STAT. On dendritic cells (DC), CD25 has been previously regarded as an activation marker, while both murine and human DC can express CD25, they do not express the beta-chain of the IL-2 receptor, which is indispensable for the execution of IL-2 signaling. The IL2RA (CD25) gene is a substantial component of the high-affinity receptor molecule highly expressed by activated T lymphocytes. Recently, a piece of strong evidence was obtained for the involvement of IL-2RA in conferring susceptibility to type 1 diabetes (T1D). Cancer growth and development are associated with the stimulation of the innate immune system, including enhanced interleukin 2 receptor (IL-2R) expression in immune cells and its shedding into the circulation in a soluble form of SIL-2Ralpha. In most hematological malignancies, including different types of leukemias and lymphomas, SIL-2Ralpha is released directly from the surface of neoplastic cells thus reflecting the tumor bulk, turnover, and activity. Several studies have proved that not only lymphoid cancer cells but also some non-lymphoid cancer cells, express IL-2R on their surface. They include malignant melanoma and carcinomas of the kidney, head and neck, esophagus, and lung. Thus, sIL-2Ralpha is elevated in most proliferative disturbances of the hematopoietic system and many solid tumors.
Research Areas
  • Neuroinflammation
  • Cancer Drug Targets
Related Pathways
  • AKT Signaling Pathway
  • Jak-Stat Signaling Pathway
  • Autophagy Pathway
  • Common G-Chain signaling pathway
Tags
  • Cancer Immunotherapy
  • Immune Checkpoint
  • Immunotherapy
  • Targeted Therapy
References
  1. Driesen J, et al. (2008) CD25 as an immune regulatory molecule expressed on myeloid dendritic cells. Immunobiology. 213(9-10): 849-58.
  2. Olejniczak K, et al. (2008) Biological properties of interleukin 2 and its role in pathogenesis of selected diseases--a review. Med Sci Monit. 14(10): RA179-89.
  3. Chistiakov DA, et al. (2008) The crucial role of IL-2/IL-2RA-mediated immune regulation in the pathogenesis of type 1 diabetes, an evidence coming from genetic and animal model studies. Immunol Lett. 118(1): 1-5.
  4. Bien E, et al. (2008) Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review. Biomarkers. 13(1): 1-26.

title: IL-2Rα KO mice exhibit maternal microchimerism and reveal nuclear localization of IL-2Rα in lymphoid and non-lymphoid cells
authors: Victoria A. Wong; Kristie N. Dinh; ...; Lucile E. Wrenshall
journal: Frontiers in Immunology
date: 2024-05-15
doi: 10.3389/fimmu.2024.1369818
pmcid: 11133634
cited_by_count: 0
techniques: Adsorption; Blocking Assay; Cell Culture; Co-Culture Assay; Cytometry; Derivative Assay; Expressing; Flow Cytometry; Fluorescence; Imaging; Immunodetection; Immunoprecipitation; Isolation; Labeling; Membrane; Microscopy; Purification; SDS Page; Sequencing; Software; Staining; Western Blot
bioz_score: 92

Reviews

Write Your Own Review
You're reviewing:Anti-CD25/IL-2R alpha Antibody, Mouse Monoclonal sinobiological 90265-MM07
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.